Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
A terminated clinical trial evaluated the effect of levocetirizine on inflammatory mediators in dermatographism, in the context of rhinitis …
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria [Phase 4]
Phase 4 trial evaluating bilastine's effect on F1 simulator driving performance in patients with allergic rhinitis and/or urticaria. Results…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Validation of an Urticaria Control Test
A completed clinical trial validating an Urticaria Control Test for monitoring chronic urticaria.
-
CLINICAL_TRIALS research · 2017-01-06Clinical Trial Update: Development of an Urticaria Control Test
A clinical trial update describing ongoing development of an urticaria control test for chronic urticaria.
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria [Phase 2]
Miltefosine was evaluated in a Phase 2 trial for antihistamine-resistant chronic urticaria; the study was terminated and results were posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria [Phase 3]
Phase 3 clinical trial investigating Chinese Herbal Medicine for chronic urticaria has completed.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Sun Pharmaceutical Industries, Inc., under the existing ANDA.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for cetirizine hydrochloride by Padagis Israel Pharmaceuticals Ltd. The document indicates the actio…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for cetirizine hydrochloride from Bionpharma Inc. This represents approval of a supplemental NDA for…
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (Chartwell RX, LLC), resulting in a labeling update for this generic p…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)
FDA approved a supplemental application for Cetirizine Hydrochloride Oral Solution from APOZEAL Pharmaceuticals Inc.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for cetirizine hydrochloride submitted by Rising Pharma Holdings, Inc. under an ANDA.
-
FDA approval · 2016-11-04FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) submitted by Bayer Healthcare LLC, under the existing NDA.
-
FDA label_change · 2016-08-23FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC, indicating a modificat…
-
FDA approval · 2016-08-12FDA Approved: CAREONE ALLERGY RELIEF — Original Application (American Sales Company)
FDA approved CAREONE ALLERGY RELIEF as an original application for cetirizine hydrochloride tablets (generic antihistamine) from American Sa…
-
FDA approval · 2016-08-09FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC.
-
FDA approval · 2016-08-05FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) to modify the labeling related to pe…
-
FDA label_change · 2016-08-01FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC. The action concerns ch…
-
FDA approval · 2016-06-10FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., marking an additiona…
-
FDA approval · 2016-05-31FDA Approved: RYVENT — Original Application (Carwin Pharmaceutical Associates, LLC)
FDA approved Ryvent (carbinoxamine maleate) in relation to its original application for this generic antihistamine from Carwin Pharmaceutica…
-
FDA approval · 2016-05-12FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize a new extended-release oral suspension formulation of carbinoxamine maleate by Neos The…
-
FDA label_change · 2016-05-10FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) from Chattem, Inc.
-
FDA approval · 2016-04-05FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add grape and bubblegum chewable forms of Claritin (loratadine) from Bayer HealthCare LLC, ex…
-
FDA approval · 2016-04-04FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) to treat hives (urticaria). The product is manufactured …
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride by Teva Pharmaceuticals USA, Inc., under ANDA088617.